Testing Lutetium Lu 177 Dotatate in Patients With Somatostatin Receptor Positive Advanced Bronchial Neuroendocrine Tumors
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Novartis
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
Instituto do Cancer do Estado de São Paulo
National Institutes of Health Clinical Center (CC)
BioNTech SE
Fundación de investigación HM
Rezolute
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
Merck Sharp & Dohme LLC
Asan Medical Center
RayzeBio, Inc.
National Institutes of Health Clinical Center (CC)
National Health Research Institutes, Taiwan
Shanghai Jiao Tong University School of Medicine
City of Hope Medical Center
Molecular Partners AG
National Institutes of Health Clinical Center (CC)
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Turning Point Therapeutics, Inc.
Memorial Sloan Kettering Cancer Center
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
RayzeBio, Inc.
Boston Scientific Corporation
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Exelixis
University of Wisconsin, Madison
Centre Oscar Lambret
Stanford University
University of California, San Francisco
Hamilton Health Sciences Corporation
National Institutes of Health Clinical Center (CC)
Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc.
Brigham and Women's Hospital
Mayo Clinic
The First Affiliated Hospital of Xiamen University
Grupo Espanol de Tumores Neuroendocrinos
University of Michigan Rogel Cancer Center
University College, London
Memorial Sloan Kettering Cancer Center
ViroMissile, Inc.
Emory University